ornithine aspartate
PolandDrugs containing this active substance
-
The drug helps to remove ammonia from the body and tissues, supporting the liver. It is used in the treatment of hepatic encephalopathy (in acute and chronic liver diseases, such as fatty liver or cirrhosis) and in hyperammonemia.
Form: solution for infusion, concentrate
Active substance Dosage ornithine aspartate 5 g/10 ml ATC: A05BA
Manufacturer: Merz Pharmaceuticals GmbH
-
The medicine helps to remove ammonia from the body and supports the liver. It is used in the treatment of hepatic encephalopathy (in acute and chronic liver diseases, such as fatty liver or cirrhosis) and in hyperammonemia.
Form: solution for infusion, concentrate
Active substance Dosage ornithine aspartate 5 g/10 ml ATC: A05BA
Manufacturer: Merz Pharmaceuticals GmbH
-
The drug is used in the treatment of hepatic encephalopathy resulting from acute or chronic liver diseases (such as cirrhosis or fatty liver) and in hyperammonemia. It helps to remove ammonia from the body and tissues.
Form: solution for infusion, concentrate
Active substance Dosage ornithine aspartate 5 g/10 ml ATC: A05BA
Manufacturer: Merz Pharmaceuticals GmbH
-
It is used in the treatment of latent and overt hepatic encephalopathy, which occurs in the course of chronic liver diseases, such as cirrhosis or chronic hepatitis.
Form: solution for oral use, granules
Active substance Dosage ornithine aspartate 3 g/5 g ATC: A05BA
Manufacturer: Merz Pharma Austria GmbH
-
It is used in the treatment of latent and overt hepatic encephalopathy occurring in the course of chronic liver diseases, such as cirrhosis or chronic hepatitis.
Form: solution for oral use, granules
Active substance Dosage ornithine aspartate 3 g/5 g ATC: A05BA
Manufacturer: Merz Pharmaceuticals GmbH
-
It is used as supportive treatment in cases of chronic liver diseases, such as fatty liver, hepatitis, cirrhosis, viral infection-related liver diseases, and toxic damage.
Form: solution for oral use, granules
Active substance Dosage ornithine aspartate 3000 mg ATC: A05BA
Manufacturer: Natur Produkt Pharma Sp. z o.o.
-
The medicine is used to treat overt and subclinical hepatic encephalopathy occurring in chronic liver diseases, such as cirrhosis or chronic hepatitis.
Form: granules for oral solution, in sachet
Active substance Dosage ornithine aspartate 6000 mg/5 g ATC: A05BA
Manufacturer: Mako Pharma Sp. z o.o.
-
It is used in the treatment of latent and overt hepatic encephalopathy occurring in the course of chronic liver diseases, such as cirrhosis or chronic hepatitis.
Form: granules for oral solution, in sachet
Active substance Dosage ornithine aspartate 3000 mg/5 g ATC: A05BA
Manufacturer: Mako Pharma Sp. z o.o.